Trial Profile
Clinical Trials Insight: 700037957
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2008
Price :
$35
*
At a glance
- Drugs Bevirimat (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- Sponsors Panacos Pharmaceuticals Inc
- 15 Oct 2008 New trial record.
- 08 Oct 2008 Results have been presented in a Panacos Pharmaceuticals media release.